Stryker Interventional Spine. Your single source for VCF solutions.
StrykerIVS.com The benefit of choice. The advantage of Stryker.
Osteoporotic fractures are a serious and growing problem for older adults and the healthcare system. In fact, one in two women and one in four men will have an osteoporotic fracture during their lifetime.1 Vertebral compression fractures (VCFs) are the most common with an estimated 700,000 such fractures reported each year.2, 3
Relieving pain. Improving lives.
With the addition of Cortoss Bone Augmentation Material, Stryker offers you a broad portfolio of products for VCF treatments. From our new iVAS Inflatable Vertebral Augmentation System to our mixer and delivery systems, cements, and needles, our unprecedented portfolio of products lets you customize your treatment approach. In fact, Stryker’s product configurations offer more flexibility, which helps contain costs and avoid waste. Every spine is unique. Now your treatment options are too.
Vertebroplasty involves injection Vertebroplasty Vertebral Augmentation of bone cement or bioactive composite15,16 directly into a fractured vertebral body from a percutaneous approach. The hardened cement or bioactive composite15,16 stabilizes the fracture, relieving pain.4,5
Vertebral compression fracture Needle is guided into fractured Vertebral augmentation is is identified vertebra using fluoroscopy a treatment option for vertebral compression fractures that creates a void in the cancellous bone by way of an inflated balloon. This procedure helps ensure controlled and contained cement delivery into Needle is guided into fractured Hand drill is inserted into the anterior third the factured vertebral body. vertebra using fluoroscopy of the vertebral body to create a pathway
Clinical results for both procedures show substantial pain relief 2,6 in approximately 90% of patients6 and potentially a significant increase in quality of life.2,7 Bone cement or bioactive composite Balloon catheter is inserted is injected into the fractured vertebra
Stabilized vertebral body The balloon is inflated, compacting the trabeculae and creating a cavity
Once the balloon is deflated and withdrawn, the cavity is filled with bone cement
Stabilized vertebral body Stryker Bioactive Composite Cortoss Bone Augmentation Material
Cortoss is an injectable, non-resorbable composite consisting of cross-linking resins and reinforcing glass ceramic particles. It has been clinically proven to meet the safety and effectiveness of Polymethylmethacrylate (PMMA) for vertebral augmentation. Cortoss material properties create flow characteristics and fill patterns that may improve procedural safety and control.
Features s Flow and Fill: Properties improve short-term pain and long-term function15 s Safety: Low incidence of adjacent fractures*15; minimal exotherm17 and monomer release18 s Control: Procedural flexibility with mix-on-demand and start/stop delivery19 s Data: Robust compilation of clinical data19
* In patients with one level treated and no previous fracture.
1992 1997-1999 2002 2003 2004 2009 2011
Orthovita founded Cortoss US IDE Pilot Study: CE Mark US IDE FDA Cleared: Stryker acquired development - a Vertebroplasty Vertebral Pivotal Study: Vertebral Orthovita bioactive glass Augmentation Vertebroplasty Augmentation 16 filled composite US IDE Pilot Study: Kyphoplasty International Multi-Center Clinical Trials Clinical testing provides the proof.15 s The safety and efficacy of Cortoss have been demonstrated in an extensive multi-centre clinical study involving three U.S. and multiple European centres15 s 30% less material was required during vertebroplasty to achieve desired fill patterns15 s In patients with a first-time fracture at one level, there was a 43% reduction in adjacent level fractures in the Cortoss patient population15
Axial View Coronal View Sagittal View Stryker Aliquot Accessories Aliquot Delivery System
With mix-on-demand, working time is no longer a concern. s The Cortoss pastes are contained in a ready-to- use dual chamber cartridge s Material preparation is an on-demand process that takes seconds to complete s The concern of “working time” is irrelevant with Cortoss as fresh material is available as the need arises
Ordering Information
Cortoss Syringe Delivery Plunger Delivery System Kit System Kit 2101-0002 Cortoss Cartridge, 5cc 2090-0501 2090-0502 Syringe Delivery System, 4" Plunger Delivery System, 4" 2101-0000 Includes: 11g 4" Bevel Tip needle, 11g Includes: 11g 4" Bevel Tip needle, 11g 4" Cortoss Cartridge, 10cc 4" Diamond Tip needle, 13g 6" Reamer, Diamond Tip needle, 13g 6" Reamer, 13g 6" 13g 6" Catheter (qty 5), Side-port syringe Catheter (qty 5), 13g 6" Plunger (qty 5) 2110-0008 (qty 5) Mixing and Delivery Gun 2110-0027 Mixing and Delivery Gun (Reusable) 2110-0031 Mix-Tips, Leur (qty 3) Intuitive injection control is fundamental to start/stop delivery. s Procedural flexibility if leaks are detected s Procedural control if needle repositioning is required s Control of operative workflow s Start and stop delivery as required until treatment goals are achieved
Ordering Information, continued
Aliquot Delivery System
2110-0505 11g 4" (10cm) Bevel Tip needle
2110-0506 13g 4" (10cm) Diamond Tip needle
2110-0501 13g 6" (15cm) Plunger
2110-0503 13g 6’’ (15cm) Catheter
2110-0507 Flexible Extension
2110-0513 Side Loading Syringe Stryker PMMA Bone Cements Once a benchmark, always a benchmark.
As one of the world’s leading manufacturers of bone cement, Stryker continues to set the industry standard by providing physicians with a range of bone cements that address specific viscosity and working time preferences for the treatment of vertebral compression fractures.
Stryker’s three unique VCF bone cements, compared at right, are indicated for use with percutaneous vertebroplasty and kyphoplasty, providing the flexibility you want and the options you need for individualized patient care.
Over the last three and a half decades, Stryker has implanted more than 23 million doses of bone cement. This expertise is grounded in Stryker’s Simplex P Bone Cement. In 1971, Simplex P became the first surgical bone cement approved by the FDA for total hip replacement. For more than 40 years, tens of thousands of physicians have trusted Stryker bone cements derived from Simplex P including SpinePlex, VertaPlex, and now VertaPlex HV.
Stryker Interventional Spine. Your single source for VCF solutions.
1958 1962 1971 1973 1975 1976
Simplex C Bone Simplex P Bone Simplex P first to Simplex P Bone Simplex antibiotic Simplex P approved Cement introduced Cement introduced receive FDA approval Cement approved Bone Cement (with for pathological in Europe in Europe in the U.S. for total for total knee Erythromycin and fractures and general hip arthroplasty arthroplasty Colistin) introduced prosthetic fixation in Europe Stryker PMMA Bone Cement Viscosity